Medpace stockholders approve amended incentive plan and simple majority voting proposal at 2025 annual meeting

Medpace Holdings, Inc.

Elected August J. Troendle (21.2M for) and Dani S. Zander (25.9M for) as Class III directors.
Ratified Deloitte & Touche as independent auditor for FY2025 (27.2M for, 600k against).
Advisory vote to approve named executive officer compensation passed (24.9M for).
Approved 2016 Amended and Restated Incentive Award Plan, extending expiration to Feb 6, 2035 (25.6M for).
Non-binding stockholder proposal for simple majority voting approved (18.2M for).

This headline and bullets were generated automatically by deepseek-v4-flash:cloud@v2 from the public filing. Read the source on SEC.gov before relying on any specific claim. Not investment advice. See methodology for how this pipeline works.